Immediate Impact
1 from Science/Nature 59 standout
Citing Papers
Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
Engineered cellular immunotherapies in cancer and beyond
2022 Standout
Works of Kirk Trisler being referenced
Abstract 147: First-in-human Phase 1/2a Study Of Intracerebral Transplantation Using Embryonic-derived Neural Stem Cells (NR1) For Chronic Ischemic Stroke
2023
Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.
1996
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kirk Trisler | 380 | 182 | 220 | 13 | 565 | |
| SJ Knox | 373 | 126 | 113 | 20 | 566 | |
| David M. Goldenberg | 378 | 99 | 84 | 14 | 568 | |
| R M Sharkey | 445 | 123 | 78 | 15 | 563 | |
| M. Fontanillas | 265 | 78 | 85 | 13 | 638 | |
| E Barendswaard | 332 | 63 | 148 | 11 | 619 | |
| G. Rowlinson | 304 | 55 | 49 | 11 | 461 | |
| Atsushi Doi | 317 | 40 | 80 | 18 | 629 | |
| Shu-Fang Hsu Schmitz | 87 | 165 | 339 | 9 | 568 | |
| Jeffrey S. Eshleman | 144 | 36 | 167 | 12 | 504 | |
| Don B. Axworthy | 519 | 202 | 83 | 14 | 628 |
All Works
Loading papers...